相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Real-time in situ viability assessment in a 3D bioreactor with liver cells using resazurin assay
Daniel Mueller et al.
CYTOTECHNOLOGY (2013)
Pyrrolidinediones reduce the toxicity of thiazolidinediones and modify their anti-diabetic and anti-cancer properties
Sudipta Saha et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
Three-Dimensional HepaRG Model As An Attractive Tool for Toxicity Testing
Sofia B. Leite et al.
TOXICOLOGICAL SCIENCES (2012)
Optimization of the HepaRG cell model for drug metabolism and toxicity studies
Sebastien Antherieu et al.
TOXICOLOGY IN VITRO (2012)
Real-time concurrent monitoring of apoptosis, cytosolic calcium, and mitochondria permeability transition for hypermulticolor high-content screening of drug-induced mitochondrial dysfunction-mediated hepatotoxicity
Jae-Ah Kim et al.
TOXICOLOGY LETTERS (2012)
In Vitro Evaluation of Major In Vivo Drug Metabolic Pathways Using Primary Human Hepatocytes and HepaRG Cells in Suspension and a Dynamic Three-Dimensional Bioreactor System
Malin Darnell et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Bile salt export pump inhibitors are associated with bile acid-dependent drug-induced toxicity in sandwich-cultured hepatocytes
Eiichiro Ogimura et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Towards automated production and drug sensitivity testing using scaffold-free spherical tumor microtissues
Maren Drewitz et al.
BIOTECHNOLOGY JOURNAL (2011)
Toxic Metabolite Formation from Troglitazone (TGZ): New Insights from a DFT Study
Vaibhav A. Dixit et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2011)
HepaRG Cells: A Human Model to Study Mechanisms of Acetaminophen Hepatotoxicity
Mitchell R. McGill et al.
HEPATOLOGY (2011)
Enhancement of drug efflux activity via MDR1 protein by spheroid culture of human hepatic cancer cells
Ayumi Oshikata et al.
JOURNAL OF BIOSCIENCE AND BIOENGINEERING (2011)
In-depth physiological characterization of primary human hepatocytes in a 3D hollow-fiber bioreactor
Daniel Mueller et al.
JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE (2011)
Scaling Down of a Clinical Three-Dimensional Perfusion Multicompartment Hollow Fiber Liver Bioreactor Developed for Extracorporeal Liver Support to an Analytical Scale Device Useful for Hepatic Pharmacological In Vitro Studies
Katrin Zeilinger et al.
TISSUE ENGINEERING PART C-METHODS (2011)
Metabolic profiling using HPLC allows classification of drugs according to their mechanisms of action in HL-1 cardiomyocytes
Alexander Strigun et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2011)
Mitochondrial CYP2E1 is sufficient to mediate oxidative stress and cytotoxicity induced by ethanol and acetaminophen
Laetitia Knockaert et al.
TOXICOLOGY IN VITRO (2011)
Cytochrome P450-Dependent Metabolism in HepaRG Cells Cultured in a Dynamic Three-Dimensional Bioreactor
Malin Darnell et al.
DRUG METABOLISM AND DISPOSITION (2011)
Comparative Analysis of Gene Expression in Rat Liver Tissue and Monolayer- and Spheroid-Cultured Hepatocytes
Yusuke Sakai et al.
CELLS TISSUES ORGANS (2010)
Extending Hepatocyte Functionality for Drug-Testing Applications Using High-Viscosity Alginate-Encapsulated Three-Dimensional Cultures in Bioreactors
Joana P. Miranda et al.
TISSUE ENGINEERING PART C-METHODS (2010)
Extracellular Matrix Modulates Sensitivity of Hepatocytes to Fibroblastoid Dedifferentiation and Transforming Growth Factor β-induced Apoptosis
Patricio Godoy et al.
HEPATOLOGY (2009)
Towards an Extended Functional Hepatocyte In Vitro Culture
Joana P. Miranda et al.
TISSUE ENGINEERING PART C-METHODS (2009)
Effects of drugs in subtoxic concentrations on the metabolic fluxes in human hepatoma cell line Hep G2
Jens Niklas et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2009)
Increased sensitivity for troglitazone-induced cytotoxicity using a human in vitro co-culture model
Ylva Edling et al.
TOXICOLOGY IN VITRO (2009)
Paracetamol (acetaminophen) pharmacodynamics: interpreting the plasma concentration
I. A. Gibb et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2008)
Recent advances in three-dimensional multicellular spheroid culture for biomedical research
Ruei-Zhen Lin et al.
Biotechnology Journal (2008)
Long-term functional stability of human HepaRG hepatocytes and use for chronic toxicity and genotoxicity studies
Rozenn Josse et al.
DRUG METABOLISM AND DISPOSITION (2008)
Evaluation of HepaRG cells as an in vitro model for human drug metabolism studies
Kajsa P. Kanebratt et al.
DRUG METABOLISM AND DISPOSITION (2008)
Primary hepatocytes as a model to analyze species-specific toxicity and drug metabolism
Gregor Tuschl et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2008)
Long-term viability and proliferation of alginate-encapsulated 3-D HepG2 aggregates formed in an ultrasound trap
D. Bazou et al.
TOXICOLOGY IN VITRO (2008)
The mitochondrial superoxide/thioredoxin-2/Ask1 signaling pathway is critically involved in troglitazone-induced cell injury to human hepatocytes
Priscilla L. K. Lim et al.
TOXICOLOGICAL SCIENCES (2008)
Determination of urea using high-performance liquid chromatography with fluorescence detection after automated derivatisation with xanthydrol
Shona Clark et al.
JOURNAL OF CHROMATOGRAPHY A (2007)
Glitazones induce astroglioma cell death by releasing reactive oxygen species from mitochondria:: Modulation of cytotoxicity by nitric oxide
Jose M. Perez-Ortiz et al.
MOLECULAR PHARMACOLOGY (2007)
Liver fibrosis in vitro:: Cell culture models and precision-cut liver slices
M. Van de Bovenkamp et al.
TOXICOLOGY IN VITRO (2007)
The human hepatoma HepaRG cells: A highly differentiated model for studies of liver metabolism and toxicity of xenobiotics
Andre Guillouzo et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2007)
Transdifferentiation of hepatocyte-like cells from the human hepatoma HepaRG cell line through bipotent progenitor
Virginie Cerec et al.
HEPATOLOGY (2007)
Dynamic analysis of hepatoma spheroid formation:: roles of E-cadherin and β1-integrin
RZ Lin et al.
CELL AND TISSUE RESEARCH (2006)
Mitochondrial permeability transition as a potential determinant of hepatotoxicity of antidiabetic thiazolidinediones
Yasuhiro Masubuchi et al.
TOXICOLOGY (2006)
Capturing complex 3D tissue physiology in vitro
LG Griffith et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Structure and function of the MRP2 (ABCC2) protein and its role in drug disposition
Gabriele Jedlitschky et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2006)
Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells
C Aninat et al.
DRUG METABOLISM AND DISPOSITION (2006)
Thiazolidenediones mediate apoptosis in prostate cancer cells in part through inhibition of Bcl-xL/Bcl-2 functions independently of PPAR-γ
CW Shiau et al.
CANCER RESEARCH (2005)
Troglitazone and liver injury: In search of answers
M Chojkier
HEPATOLOGY (2005)
Microscale tissue engineering using gravity-enforced cell assembly
JM Kelm et al.
TRENDS IN BIOTECHNOLOGY (2004)
Involvement of organic anion transporting polypeptides in the transport of troglitazone sulfate: Implications for understanding troglitazone hepatotoxicity
T Nozawa et al.
DRUG METABOLISM AND DISPOSITION (2004)
Metabolic activation of troglitazone: Identification of a reactive metabolite and mechanisms involved
K He et al.
DRUG METABOLISM AND DISPOSITION (2004)
Design of artificial myocardial microtissues
JM Kelm et al.
TISSUE ENGINEERING (2004)
Method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell types
JM Kelm et al.
BIOTECHNOLOGY AND BIOENGINEERING (2003)
Troglitazone but not rosiglitazone induces G1 cell cycle arrest and apopiosis in human and rat hepatoma cell lines
MA Bae et al.
TOXICOLOGY LETTERS (2003)
The impact of cytochrome P450 2E1-dependent metabolic variance on a risk-relevant pharmacokinetic outcome in humans
JC Lipscomb et al.
RISK ANALYSIS (2003)
Infection of a human hepatoma cell line by hepatitis B virus
P Gripon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Differential in vitro hepatotoxicity of troglitazone and rosiglitazone among cryopreserved human hepatocytes from 37 donors
S Lloyd et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2002)
Futile cycles revisited: A Markov chain model of simultaneous glycolysis and gluconeogenesis
ME Jones et al.
JOURNAL OF THEORETICAL BIOLOGY (2002)
Structural polarity and functional bile canaliculi in rat hepatocyte spheroids
SF Abu-Absi et al.
EXPERIMENTAL CELL RESEARCH (2002)
Formation of a novel quinone epoxide metabolite of troglitazone with cytotoxic to HepG2 cells
Y Yamamoto et al.
DRUG METABOLISM AND DISPOSITION (2002)
Implications of the simultaneous occurrence of hepatic glycolysis from glucose and gluconeogenesis from glycerol
JW Phillips et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2002)
Enzyme-induction dependent bioactivation of troglitazone and troglitazone quinone in vivo
JN Tettey et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2001)
Diabetic KKAy mice exhibit increased hepatic PPARγ1 gene expression and develop hepatic steatosis upon chronic treatment with antidiabetic thiazolidinediones
M Bedoucha et al.
JOURNAL OF HEPATOLOGY (2001)
Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation
EL LeCluyse
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2001)
Studies on the metabolism of troglitazone to reactive intermediates in vitro and in vivo. Evidence for novel biotransformation pathways involving quinone methide formation and thiazolidinedione ring scission
K Kassahun et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2001)
Troglitazone prevents fatty changes of the liver in obese diabetic rats
DM Jia et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2000)
Down-regulation by troglitazone of hepatic tumor necrosis factor-α and interleukin-6 mRNA expression in a murine model of non-insulin-dependent diabetes
S Sigrist et al.
BIOCHEMICAL PHARMACOLOGY (2000)
分享论文
